Management of fracture risk in Parkinson's:A revised algorithm and focused review of treatments
Autor: | Arti Bhimjiyani, Jigisha Amin, Celia L Gregson, Christopher Kobylecki, Emily J. Henderson, Veronica Lyell |
---|---|
Jazyk: | angličtina |
Rok vydání: | 2019 |
Předmět: |
Male
0301 basic medicine FRAX Osteoporosis Population Risk Assessment BTC (Bristol Trials Centre) Fractures Bone 03 medical and health sciences 0302 clinical medicine Risk Factors Health care medicine Humans education Aged Aged 80 and over education.field_of_study Hip fracture business.industry Absolute risk reduction Parkinson Disease Guideline Middle Aged medicine.disease 030104 developmental biology Neurology Ageing and Movement Research Group Female BRTC Neurology (clinical) Geriatrics and Gerontology business Risk assessment Algorithm Algorithms 030217 neurology & neurosurgery |
Zdroj: | Henderson, E, Lyell, V, Bhimjiyani, A, Amin, J, Kobylecki, C & Gregson, C 2019, ' Management of fracture risk in Parkinson's : A revised algorithm and focused review of treatments ', Parkinsonism and Related Disorders . https://doi.org/10.1016/j.parkreldis.2019.03.021 |
DOI: | 10.1016/j.parkreldis.2019.03.021 |
Popis: | IntroductionFalls and fractures are a cause of substantial morbidity in Parkinson's. Despite an excess risk of both falls and osteoporosis, people with Parkinson's perceive that they are less likely to fracture than their peers, despite actually being at higher fracture risk. Recognising this increased risk, in 2014 we published an algorithm to guide management of fracture risk in this high-risk population. Recently, the National Osteoporosis Guideline Group (NOGG) published new guidance revising the 10 year fracture probability intervention thresholds for those over 70 years old to 20.3% for major osteoporotic fracture and 5.4% for hip fracture.MethodsIn light of the new guidance, we have reappraised the use of two fracture prediction tools, Qfracture and FRAX, and have updated the algorithm to guide the management of bone health and fracture risk in people with Parkinson's.ResultsWe outline the treatment options available with particular consideration given to Parkinson specific factors that influence treatment choices.ConclusionThis guidance is relevant to all healthcare specialist managing Parkinson's including neurologists, geriatricians and primary care practitioners. |
Databáze: | OpenAIRE |
Externí odkaz: |